Wrap up: Pharmaceutical company pleads guilty to falsifying prescription orders, and other news

Happy Friday dvm360 readers! We hope this past Fourth of July weekend gave you some time to relax and decompress. For those who may have a missing or found pet over the holiday break, Petco’s Love Lost database for lost pets may provide some guidance.

As you get back into the flow of things, take some time to check out this week’s top stories on dvm360.com:

• Jenifer Chatfield, DVM, DACZM, DACVPM, shared “3 Truths and a lie” about canine leptospirosis at the annual AVMA Convention in Austin, Texas.
• The first generic methimazole oral solution for treating cats with hyperthyroidism— the most common endocrine disease in middle-aged cats and older—was recently approved by the FDA.
• Kathryn Junkins Sarpong, DVM, DABVP (canine/feline), discussed the nutritional needs of felines and canines with diabetes, and went over evaluation practices for monitoring newly diagnosed patients with diabetes.
• Researchers from various universities announced the development of a new bovine tuberculosis vaccine that uses probiotics to survive the gut of white-tailed deer.
• Nicola A. Lakeman, MSc, BSc, (Hons), RVN, CertVNECC, CertSAN, VTS (Nutrition), talked about the changing microbiome of felines as they age, in an interview with dvm360 at the American College of Veterinary Internal Medicine Forum in Minneapolis, Minnesota.
• US Compounding Inc (USC), a subsidiary of DMK Pharmaceutical Corporation, pleaded guilty to distributing prescription drugs with sham prescriptions through an arrangement with a veterinarian.
• And more!